Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients.
Diagnostics (Basel). 2020 Oct 23;10(11):864. doi: 10.3390/diagnostics10110864.
Diagnostics (Basel). 2020.
PMID: 33114033
Free PMC article.
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients.
Szarvas T, Hoffmann MJ, Olah C, Szekely E, Kiss A, Hess J, Tschirdewahn S, Hadaschik B, Grotheer V, Nyirady P, Csizmarik A, Varadi M, Reis H.
Szarvas T, et al.
Diagnostics (Basel). 2020 Dec 31;11(1):48. doi: 10.3390/diagnostics11010048.
Diagnostics (Basel). 2020.
PMID: 33396213
Free PMC article.
Item in Clipboard
High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy.
Krafft U, Olah C, Reis H, Kesch C, Darr C, Grünwald V, Tschirdewahn S, Hadaschik B, Horvath O, Kenessey I, Nyirady P, Varadi M, Modos O, Csizmarik A, Szarvas T.
Krafft U, et al.
Cancers (Basel). 2021 May 22;13(11):2548. doi: 10.3390/cancers13112548.
Cancers (Basel). 2021.
PMID: 34067347
Free PMC article.
Item in Clipboard
Cite
Cite